DE60032620D1 - Mittel gegen krebs - Google Patents

Mittel gegen krebs

Info

Publication number
DE60032620D1
DE60032620D1 DE60032620T DE60032620T DE60032620D1 DE 60032620 D1 DE60032620 D1 DE 60032620D1 DE 60032620 T DE60032620 T DE 60032620T DE 60032620 T DE60032620 T DE 60032620T DE 60032620 D1 DE60032620 D1 DE 60032620D1
Authority
DE
Germany
Prior art keywords
against cancer
medium against
derivatives
anticancer agents
fibroblasts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032620T
Other languages
English (en)
Other versions
DE60032620T2 (de
Inventor
Noboru Kaneko
Kazuto Nishio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60032620D1 publication Critical patent/DE60032620D1/de
Publication of DE60032620T2 publication Critical patent/DE60032620T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DE60032620T 1999-09-30 2000-09-29 Antikrebsmittel Expired - Lifetime DE60032620T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28087499 1999-09-30
JP28087499 1999-09-30
PCT/JP2000/006786 WO2001022968A1 (fr) 1999-09-30 2000-09-29 Agents anticancereux

Publications (2)

Publication Number Publication Date
DE60032620D1 true DE60032620D1 (de) 2007-02-08
DE60032620T2 DE60032620T2 (de) 2007-10-04

Family

ID=17631164

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60034494T Expired - Lifetime DE60034494T2 (de) 1999-09-30 2000-09-29 Verwendung von Diphenylmethylpiperazin-Derivaten zur Herstellung eines Medikaments zur Unterdrückung der Proliferation von Fibroblasten
DE60032620T Expired - Lifetime DE60032620T2 (de) 1999-09-30 2000-09-29 Antikrebsmittel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60034494T Expired - Lifetime DE60034494T2 (de) 1999-09-30 2000-09-29 Verwendung von Diphenylmethylpiperazin-Derivaten zur Herstellung eines Medikaments zur Unterdrückung der Proliferation von Fibroblasten

Country Status (8)

Country Link
US (1) US6683083B1 (de)
EP (2) EP1222924B1 (de)
AT (2) ATE349212T1 (de)
AU (1) AU776745B2 (de)
CA (1) CA2385996C (de)
DE (2) DE60034494T2 (de)
TW (1) TWI289450B (de)
WO (1) WO2001022968A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
EP1603450A4 (de) 2003-03-07 2009-07-29 Univ Columbia Verfahren auf basis von typ 1 ryanodin-rezeptor
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US20070052304A1 (en) * 2005-09-07 2007-03-08 Philippe Masson Multi-pattern high temperature superconducting motor using flux trapping and concentration
JP5318938B2 (ja) * 2011-06-09 2013-10-16 株式会社アエタスファルマ ジフェニルメチルピペラジン誘導体、及びそれを用いた医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340821C (en) * 1988-10-06 1999-11-16 Nobuyuki Fukazawa Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
JP2651043B2 (ja) 1990-07-10 1997-09-10 麒麟麦酒株式会社 ジフェニルメチルピペラジン誘導体
JP2518965B2 (ja) * 1990-09-21 1996-07-31 三井東圧化学株式会社 新規ピリジン誘導体及びそれを有効成分として含有する制癌剤効果増強剤

Also Published As

Publication number Publication date
EP1222924A1 (de) 2002-07-17
EP1222924A4 (de) 2004-08-04
EP1637140A1 (de) 2006-03-22
EP1637140B1 (de) 2007-04-18
CA2385996C (en) 2008-02-12
ATE359788T1 (de) 2007-05-15
DE60032620T2 (de) 2007-10-04
US6683083B1 (en) 2004-01-27
TWI289450B (en) 2007-11-11
DE60034494D1 (de) 2007-05-31
DE60034494T2 (de) 2008-01-03
WO2001022968A1 (fr) 2001-04-05
AU776745B2 (en) 2004-09-23
CA2385996A1 (en) 2001-04-05
EP1222924B1 (de) 2006-12-27
ATE349212T1 (de) 2007-01-15
AU7449800A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
DE60032620D1 (de) Mittel gegen krebs
TR200200717T2 (tr) Terapötik kinazolin türevleri.
AU2001252609A1 (en) Imidazopyridine derivatives
TR200102490T2 (tr) Fenil ve piridinil türevleri
EP1595543A3 (de) Antineoplastische pharmazeutische Zusammensetzungen enthaltend Taurolidin oder Taurultam und 5-Fluorouracil
DE60045426D1 (de) Phenyl-benzyl-ketone
EP0902007A4 (de) Chalcon-derivate und medikamente die diese enthalten
WO1999020606A3 (en) Piperidines and piperazines as platelet aggregation inhibitors
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
IT1311922B1 (it) Composti farmaceutici.
CY1104996T1 (el) 9α-αζαλιδια εχοντα αντιβακτηριακην δρασιν
ATE456952T1 (de) Löslich gemachte topoisomerase-gifte
EE200000472A (et) Kasvajavastased toimeained
PT992509E (pt) Novos derivados macrolidos
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
NO20024662D0 (no) Prodroger av imidazopyridinderivater
CA2317604A1 (en) Matrix metalloprotease inhibitors
DK0380038T3 (da) 3-Phenyl-5,6-dihydrobenz(c)acridin-7-carboxylsyrer og beslægtede forbindelser som kemoterapeutiske midler mod cancer
DK0916670T3 (da) Pyrrolo[3,2-b]pyridiner og deres anvendelse som 5-HT1f-agonister
DK0629615T3 (da) Indolderivater som glutamatantagonister
WO2001046178A3 (en) Substituierte bisindolymaleimide
IL149306A0 (en) Benzamidine derivatives and pharmaceutical compositions containing the same
NO20013715D0 (no) Karbamatderivater av diaryl 1,3,4-oksadiazolon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition